Routine compliance filing under SEBI Regulation 74(5) for Q2 FY26

Compliance View source PDF Explain this filing

KRMAYURVED · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.7%Reaction day

₹264.00

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.2%+2.5% vs market

On the reaction day the stock moved 2.5 pts more than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs market

Reaction day

+2.7+0.2+2.5

Next day

+1.5+0.9+0.6

+0.8-0.8+1.5

-1.1-0.1-1.1

-6.3-1.7-4.5

-9.5-4.3-5.2

-9.5-7.5-2.1

15d

———

UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

KRM Ayurveda filed a compliance certificate under SEBI Regulation 74(5) for the quarter ended 30 September 2026. Its Registrar, Skyline Financial Services, confirmed that no physical share certificates were received for dematerialisation during the quarter. Total equity shares stand at around 2.12 crore, fully held in demat form (about 1.74 crore in NSDL and 0.38 crore in CDSL). This is a routine quarterly regulatory submission with no change to shareholding or capital structure.

Likely market impact

No impact on shareholders. Routine regulatory filing with no change in shareholding pattern or capital structure.